Search - tctmd.com

Displaying 101 - 120 of 602

Sort: Relevancy | Date

Presentation TCT 2023

TCT 158: The Impact of Sex And Age On Long-term Outcome After Percutaneous Coronary Interventions – A Pooled Analysis Of The Randomized Controlled SORT OUT Trials

Presenter: Emil Holck

October 26, 2023

Presentation TCT 2023

TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 26, 2023

Presentation TCT 2023

TCT 623: Effects of Complete Revascularization in Relation to Left Ventricular Function in Patients with STEMI and Multivessel Disease: Data from the COMPLETE Randomized trial

Presenter: Denise Tiong

October 26, 2023

Presentation TCT 2023

TCT 357: Immediate Complete Revascularization in Patients Presenting With Acute Coronary Syndrome and Extensive Coronary Artery Disease: Insights From the BIOVASC Trial

Presenter: Hala Kakar

October 26, 2023

Presentation TCT 2023

LAAO as First Line Stroke Prevention Therapy: Are CHAMPION-AF and CATALYST Trials Likely to Succeed?

Presenter: Vivek Reddy

October 26, 2023

Presentation TCT 2023

TCT 462: Immediate Versus Staged Complete Revascularisation Angina-Related Quality of Life in patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease : Results From the Prospective, Open-Label, Non-Inferiority, Randomised…

Presenter: Paul Cummins

October 26, 2023

Presentation TCT 2023

First-in-Man Intravascular Fluorescence Lifetime ImaGing for Highly-Sensitive Molecular Characterization of Coronary AtheromaTa (FLIGHT Trial)

Presenter: Jin Won Kim

October 26, 2023

Presentation TCT 2023

Optical Coherence Tomography-based Functional Stenosis Assessment: FUSION - A Prospective Multi-Center Trial

Presenter: Allen Jeremias

October 26, 2023

News Conference News TCT 2023

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Michael O'Riordan

October 25, 2023

Presentation TCT 2023

Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials

Presenter: Yousif Ahmad

October 25, 2023

Presentation TCT 2023

How I Have Started to Use DCB’s: A Look into the Future

Presenter: Antonio Colombo

October 25, 2023

Presentation TCT 2023

Backbeat Clinical Trial Program (Pacemaker-Mediated Blood Pressure Lowering)

Presenter: Daniel Burkhoff

October 25, 2023

Presentation TCT 2023

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

Presenter: Kirstine Hansen

October 25, 2023

Presentation TCT 2023

AGENT-IDE Deeper Dive: Key Subgroups and Perspectives

Presenter: Ajay Kirtane

October 25, 2023

Presentation TCT 2023

IBERIS Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: Felix Mahfoud

October 25, 2023

Presentation TCT 2023

TCT 356: Patients with moderate to severe lesion tortuosity undergoing coronary intervention with newer-generation drug eluting stents – an analysis from the randomized BIOFLOW trials

Presenter: Rayyan Hemetsberger

October 25, 2023

Presentation TCT 2023

Treatment of Aortic Regurgitation Using Dedicated TAVR Systems: Early European Experiences and Description of the Align AR Trial

Presenter: Stephan Baldus

October 25, 2023

Presentation TCT 2023

TARGET Clinical Trial Program (Alcohol-Mediated Renal Denervation)

Presenter: David Kandzari

October 25, 2023

Presentation TCT 2023

SYMAP Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: Felix Mahfoud

October 25, 2023

Presentation TCT 2023

AGENT-IDE Data Dive: Background, Trial Design, and Primary Results

Presenter: Robert Yeh

October 25, 2023

Advertisement

TCT 158: The Impact of Sex And Age On Long-term Outcome After Percutaneous Coronary Interventions – A Pooled Analysis Of The Randomized Controlled SORT OUT Trials

TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation

TCT 623: Effects of Complete Revascularization in Relation to Left Ventricular Function in Patients with STEMI and Multivessel Disease: Data from the COMPLETE Randomized trial

TCT 357: Immediate Complete Revascularization in Patients Presenting With Acute Coronary Syndrome and Extensive Coronary Artery Disease: Insights From the BIOVASC Trial

LAAO as First Line Stroke Prevention Therapy: Are CHAMPION-AF and CATALYST Trials Likely to Succeed?

TCT 462: Immediate Versus Staged Complete Revascularisation Angina-Related Quality of Life in patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease : Results From the Prospective, Open-Label, Non-Inferiority, Randomised…

First-in-Man Intravascular Fluorescence Lifetime ImaGing for Highly-Sensitive Molecular Characterization of Coronary AtheromaTa (FLIGHT Trial)

Optical Coherence Tomography-based Functional Stenosis Assessment: FUSION - A Prospective Multi-Center Trial

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials

How I Have Started to Use DCB’s: A Look into the Future

Backbeat Clinical Trial Program (Pacemaker-Mediated Blood Pressure Lowering)

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

AGENT-IDE Deeper Dive: Key Subgroups and Perspectives

IBERIS Clinical Trial Program (Radio-Frequency Renal Denervation)

TCT 356: Patients with moderate to severe lesion tortuosity undergoing coronary intervention with newer-generation drug eluting stents – an analysis from the randomized BIOFLOW trials

Treatment of Aortic Regurgitation Using Dedicated TAVR Systems: Early European Experiences and Description of the Align AR Trial

TARGET Clinical Trial Program (Alcohol-Mediated Renal Denervation)

SYMAP Clinical Trial Program (Radio-Frequency Renal Denervation)

AGENT-IDE Data Dive: Background, Trial Design, and Primary Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content